Cytex Therapeutics, Inc.

CIK: 1943908DEIncorporated: 2006-07-21

Current Offering

$10,000
Target Amount
$1,070,000
Maximum Amount
2023-01-24
Deadline

Security Details

Type: Series B-CF Non-Voting Common Stock
Price per share: $2.00
Shares offered: 5,000+

Offering Costs

Cash commission: 13%
7 - 13 percent
Equity compensation: 2%
We charge 2% commission paid in equity or securities at the same rate as this offering.

Financial Reports

Offering via StartEngine

Offering History

As of 2022-10-26
Raising $10,000 -$1,070,000 via 5,000+ shares of series B-CF Non-Voting Common Stock at $2.00 per share
Deadline: 2023-01-24
Filing date2022-10-26
Current employees8
Act received most recent fiscal year$66,611
Act received prior fiscal year$197,422
Cash equi most recent fiscal year$489,299
Cash equi prior fiscal year$267,208
Cost goods sold most recent fiscal year$1,263,476
Cost goods sold prior fiscal year$1,288,308
Long term debt most recent fiscal year$0.00
Long term debt prior fiscal year$0.00
Net income most recent fiscal year-$22,653.00
Net income prior fiscal year$40,442
Revenue most recent fiscal year$1,836,602
Revenue prior fiscal year$1,845,230
Short term debt most recent fiscal year$144,543
Short term debt prior fiscal year$233,574
Tax paid most recent fiscal year$0.00
Tax paid prior fiscal year$0.00
Total asset most recent fiscal year$626,138
Total asset prior fiscal year$480,707

Company Information

Corporation
DE
2006-07-21

Latest Metrics

Employees8
Total Assets$626,138
Cash on Hand$489,299
Revenues$1,836,602
Net Income-$22,653.00

Crowdfunding Portals

This company is raising funds through this portal